Organised and funded by GSK.
For UK healthcare professionals.
This site contains promotional material.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com
Be part of the illuminate community today, register below.
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
To stay up to date with the latest peer-led, practical resources designed to support your professional development and the implementation of immunisation programmes, please register.
Thank you for registering
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateSeptember 2023 | PM-GB-AVU-WCNT-230007
You seem to be interested in what illuminate has to offer... why not register to stay updated
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
To stay up to date with the latest peer-led, practical resources designed to support your professional development and the implementation of immunisation programmes, please register.
Thank you for registering
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateOctober 2023 | PM-GB-AVU-WCNT-230008
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
No eligible patient should miss out on the opportunity to be protected from shingles.
3 actions you can take to maximise Shingles Awareness Week 2024 (26th Feb – 3rd March)
Dedicated Clinics
Plan dedicated shingles clinics during Shingles Awareness Week
Proactive Call & Recall
Send additional invites or reminders during Shingles Awareness Week
Engage with our supportive content!
Practical resources & webinars designed to support your programme implementation
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
Register to stay updated with the latest peer-led, practical resources designed to support programme implementation!
Thank you for registering
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441
For the GB and NI SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
January 2024 | PM-GB-AVU-WCNT-240001
Welcome to Peers in Practice
For UK healthcare professionals — information and support on healthcare challenges and primary care issues
Important notice: This content is intended for UK healthcare professionals.
By entering this site, you are confirming you are a UK healthcare professional. The HCP Clinical Hub section of this site contains promotional information.
If you are not a healthcare professional, please select ‘I’m a member of the UK public’.
February 2025 | NP-GB-CEP-WCNT-230001
You are now leaving this GSK website to visit a third-party website that is not owned or controlled by GSK. GSK does not recommend, endorse or accept liability for websites controlled by third-parties.
February 2025 | NP-GB-CEP-WCNT-230016
Log in to access this content
This content is for UK healthcare professionals only. If you have already registered, enter your email address below to log in.
Not registered? Register now to access this content.
March 2023 | NP-GB-CEP-WCNT-230003
Organised and funded by GSK. For UK healthcare professionals only. This site contains promotional material.
Welcome to illuminate
For UK healthcare professionals – this site contains promotional information.
I’m a UK healthcare professional
Important notice: This site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional.
I'm a member of the UK public
This site is intended for members of the UK public, patients and their carers.
June 2023 | NP-GB-SGX-WCNT-230003
Organised and funded by GSK. For UK healthcare professionals only. This site contains promotional material.
Welcome to illuminate
For UK healthcare professionals – This section of the site contains promotional information. Please confirm you understand this by clicking the button below.
Important notice: This site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional.
June 2023 | NP-GB-SGX-WCNT-230005
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
Your patients attending winter vaccination clinics may also be eligible for non-seasonal shingles vaccination
How can you proactively plan for non-seasonal shingles vaccination, during the winter period?
Organise & implement dedicated clinics
Highlight the schedule consists of two-doses
Engage with illuminate’s practical resources
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
Register to stay updated with the latest peer-led, practical resources designed to support programme implementation!
Thank you for registering
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the GB and NI SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
July 2024 | PM-GB-AVU-WCNT-240007
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
Your patients attending winter vaccination clinics may also be eligible for non-seasonal shingles vaccination
How can you proactively plan for non-seasonal shingles vaccination, during the winter period?
Organise & implement dedicated clinics
Highlight the schedule consists of two-doses
Engage with illuminate’s practical resources
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
Register to stay updated with the latest peer-led, practical resources designed to support programme implementation!
Thank you for registering
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the GB and NI SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
July 2024 | PM-GB-AVU-WCNT-240007
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
One year on… are you continuing to seize the opportunity to help protect your patients from shingles?
Access peer-led, solution focussed resources
Support your understanding of the Shingles National Immunisation Programme criteria
Simplify the planning and implementation of vaccination clinics
Learn from your peers and drive immunisation best practice
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
Register to stay updated with the latest peer-led, practical resources designed to support programme implementation!
Thank you for registering
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the GB and NI SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
August 2024 | PM-GB-AVU-WCNT-240008
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
Are you on track with shingles vaccination in your practice?
Maximise shingles immunity by ensuring completion of the full Two-Dose Vaccination Schedule
Plan and Implement dedicated Shingles clinics
Identify and proactively recall first and second dose patients for the shingles vaccination
Engage with practical resources, like Patient Support Materials, on Illuminate
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
Register to stay updated with the latest peer-led, practical resources designed to support programme implementation!
Thank you for registering
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the GB and NI SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
PM-GB-AVU-WCNT-240006 | August 2024
Organised and funded by GSK. For UK healthcare professionals only. This site contains promotional material.
Welcome to inhale
For UK healthcare professionals — This section of the site contains promotional information
I’m a UK healthcare professional
Important notice: This site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional.
I'm a member of the UK public
This site is intended for members of the UK public, patients and their carers.
November 2024 | NP-GB-FVU-WCNT-240001
This website is organised and funded by GSK. Adverse event reporting and prescribing information can be found below the registration form.
No eligible patient should miss out on the opportunity to be protected from shingles.
3 actions you can take to maximise Shingles Awareness Week 2025 (24th February – 2nd March)
Dedicated Clinics
Plan dedicated shingles clinics during Shingles Awareness Week
Proactive Call & Recall
Send additional invites or reminders during Shingles Awareness Week
Engage with our supportive content!
Practical resources & webinars designed to support your programme implementation
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
Register to stay updated with the latest peer-led, practical resources designed to support programme implementation!
Thank you for registering
We will be in touch when more resources for you are added to illuminate!
Go back to exploring illuminateAdverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@gsk.com.
For the SHINGRIX® (herpes zoster vaccine, recombinant, adjuvanted) prescribing information, click here.
February 2025 | PM-GB-AVU-WCNT-250001
Be part of the inhale professional hub today. Register below.
Organised and funded by GSK. For UK healthcare professionals. This site contains promotional material.
To stay up to date with upcoming COPD resources to support your professional development and the implementation of behaviour change principles in your practice, please register.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.
For the GB and NI Trelegy Ellipta® (fluticasone furoate/umeclidinium/vilanterol) prescribing information Click here.
Thank you for registering
We will be in touch when more resources for you are added to inhale.
Go back to exploring inhaleNovember 2024 | PM-GB-CPU-WCNT-240019